Gynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, Paris, France.
Research unit in Morphogenesis, Radiology and Anatomy EA4465 Paris Descartes Medical School, Paris, France.
J Gynecol Oncol. 2019 May;30(3):e34. doi: 10.3802/jgo.2019.30.e34.
The aim of this study was to determine the predictive factors of postoperative morbidity of patients who have undergone a radical trachelectomy (RT) for early-stage cervical cancer and to assess the oncologic outcomes.
We retrospectively analysed the data of 2 prospective trials on sentinel node biopsy for cervical cancer (SENTICOL I and II). Patients having a RT for early-stage cervical cancer with negative sentinel lymph node and safe margins, were included.
Forty-nine patients met the inclusion criteria. Forty-five patients had a laparoscopic-assisted vaginal technique and 4 patients a total laparoscopic technique. The median age was 32 years (range, 22-46 years). 83.7% of patients had a stage IB1 disease. There were 63.3% squamous cell carcinomas and 34.7% adenocarcinomas. The median follow-up was 46 months (range, 1-85 months). Two patients (3.3%) had a severe postoperative complication (Clavien-Dindo ≥III and/or CTCAE ≥3). The main postoperative complications were urinary (28.6%), lymphovascular (26.5%) and neurologic (14.3%). On a multivariate analysis, postoperative complications were significantly associated with history of pelvic surgery and IB1 International Federation of Gynecology and Obstetrics stage. Inclusion in high surgical skills centers decrease the risk of postoperative complications. During the follow-up, 3 patients (6.1%) had a local recurrence and one patient died from a breast cancer. Between group with complications and group without any complications, overall survival and recurrence-free survival did not significantly differ at 5-year of follow-up.
RT has few severe postoperative complications and appears as a safe alternative to spare fertility of young patients. To guarantee best surgical outcomes, patients should be referred to expert center.
本研究旨在确定行根治性宫颈切除术(RT)的早期宫颈癌患者术后发病率的预测因素,并评估其肿瘤学结局。
我们回顾性分析了两项关于宫颈癌前哨淋巴结活检的前瞻性试验(SENTICOL I 和 II)的数据。纳入接受 RT 治疗且前哨淋巴结阴性和安全切缘的早期宫颈癌患者。
49 例患者符合纳入标准。45 例患者采用腹腔镜辅助阴道技术,4 例患者采用全腹腔镜技术。中位年龄为 32 岁(范围,22-46 岁)。83.7%的患者为 IB1 期疾病。鳞状细胞癌占 63.3%,腺癌占 34.7%。中位随访时间为 46 个月(范围,1-85 个月)。2 例患者(3.3%)发生严重术后并发症(Clavien-Dindo≥III 级和/或 CTCAE≥3 级)。主要术后并发症为泌尿系统(28.6%)、淋巴血管(26.5%)和神经系统(14.3%)并发症。多因素分析显示,术后并发症与盆腔手术史和 IB1 国际妇产科联合会(FIGO)分期显著相关。纳入高手术技能中心可降低术后并发症的风险。在随访期间,3 例患者(6.1%)发生局部复发,1 例患者死于乳腺癌。在有并发症组和无并发症组中,5 年随访时总生存率和无复发生存率无显著差异。
RT 术后严重并发症较少,似乎是保留年轻患者生育能力的安全替代方法。为了保证最佳的手术效果,患者应转诊至专家中心。